GlobeNewswire

Nasdaq Corporate Solutions Unveils Nasdaq Boardvantage®, its Next Generation Board Portal and Team Collaboration Software

Dela

Will Leverage Best Features from Current Nasdaq Platforms and Combine Advancements in Cloud-based Collaboration Technology

NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Nasdaq Corporate Solutions, a business of Nasdaq, Inc. (Nasdaq:NDAQ), today unveils its next generation board portal and team collaboration software, Nasdaq Boardvantage. Nasdaq Boardvantage is available as a web-based, tablet and mobile solution and offers enhanced governance and collaboration solutions for C-suite leadership, board members, corporate secretaries, and other corporate and private organization professionals beyond the boardroom. The new product will introduce a suite of new services and features as well as combine the best features from two of Nasdaq Corporate Solutions' most popular products: Nasdaq Directors Desk® and Boardvantage MeetX®.

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/20640da9-ffc5-4844-bf56-73ba4f18146f

http://www.globenewswire.com/NewsRoom/AttachmentNg/5f431a88-2891-4223-a55d-e2e735637149

"Our board portal and team collaboration solutions are a critical foundation of the Nasdaq Corporate Solutions product offering as well as any company's governance framework," said Stacie Swanstrom, Executive Vice President and Head of Nasdaq Corporate Solutions. "We are intensely focused on the needs of corporate boards and leadership teams and, with the release of Nasdaq Boardvantage, stand proud to offer clients with a next generation software solution that helps further strengthen governance, engagement and collaboration throughout their organizations."

Key features of Nasdaq Boardvantage planned for release include:

  • A flexible and updated user interface with enhanced functions to the administration module;
  • Advanced search, featuring improved responsiveness and granular criteria;
  • Improved management of version control and alerting; and
  • Collaboration with in-document discussions, annotations, votes and e-signatures.

Nasdaq Corporate Solutions has observed a growing global trend driving increased demand for our board portal tools, notably the need to collaborate and share confidential information and documents across internal and external teams in a highly secured environment. Many C-suite executives who already use Nasdaq's board portal tools for board-level collaboration are now cascading that capability down into their organizations, all through a single sign-on service.  Nasdaq Boardvantage has been specifically designed to make it easy for clients to create multiple team spaces for different business teams to use the product to streamline file sharing, editing and e-signatures.

To learn more about Nasdaq Boardvantage please visit: http://business.nasdaq.com/intel/Boardvantage/index.html

The Nasdaq Corporate Solutions business of Nasdaq, Inc. has continuously invested in enhancements to its board portal and collaboration platforms to support better workflows in response to client feedback. In June 2017, Nasdaq Corporate Solutions announced a partnership with the Center for Board Excellence to offer a suite of corporate governance tools including, board assessments and compliance questionnaires. In August 2017, Nasdaq Corporate Solutions announced the addition of two Ontario-based data centers in response to growing demand for its board portal solutions in Canada. Over 100,000 corporate users in over 70 countries rely on Nasdaq Corporate Solutions for corporate governance and team collaboration software. Nasdaq Corporate Solutions is proud of its unique user universe, which includes CEOs, corporate secretaries, business leaders, general counsels, chief risk officers, directors, and board chairs from a diverse mix of corporate clients including: public and private companies, non-profit organizations, law firms, private equity firms, and hospital systems, among others. 

About Nasdaq: 

Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $12 trillion. To learn more, visit: http://business.nasdaq.com.

This communication and the content found by following any link herein are being provided to you by Nasdaq Corporate Solutions, a business of Nasdaq, Inc. ("Nasdaq"), for informational purposes only. Nasdaq makes no representation or warranty with respect to this communication or such content and expressly disclaims any implied warranty under law. Nasdaq, the Nasdaq logo, Nasdaq Corporate Solutions and Boardvantage are registered and unregistered trademarks, or service marks, of Nasdaq, Inc. or its subsidiaries in the U.S. and other countries. © Nasdaq, Inc. 2017. All rights reserved.

Nasdaq Media Contact:

Will Briganti
(212) 231-5012
william.briganti@nasdaq.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nasdaq via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum